Efficacy of Dapagliflozin versus Empagliflozin on Glycemic Control and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. World Journal of Current Medical and Pharmaceutical Research, India, v. 8, n. 2, p. 185–189, 2026. DOI: 10.37022/wjcmpr.v8i2.415. Disponível em: https://wjcmpr.org/index.php/journal/article/view/415. Acesso em: 13 sep. 2026.